Non-squamous, non-small-cell lung cancer patients: pemetrexed (500 mg/m2, d1) plus carboplatin (AUC = 5; d1, Q3W); lung squamous cell carcinoma patients: albumin-bound paclitaxel (100 mg/m2, d1, d8 and d15) plus cisplatin (75 mg/m2, d1, Q3W). Here, ALB is linked to squamous cell lung carcinoma.